Cologne researchers find the connection between obesity and tumor growth
According to the World Health Organization’s International Agency for Research on Cancer, colorectal cancer is the third most common cancer type in men and the second most common in women. Eight out of top ten countries in the world with the highest rates of incidence of colorectal cancer are EU countries.
Diet and lifestyle habits, in particular, play a fundamental role, as overweight people are at an increased risk of developing cancer. Scientists from the Max Planck Institute for Metabolism Research in Cologne have now uncovered the links between these two diseases and provide new therapeutic approaches for the prevention of obesity-associated cancers.
"If the body has to store more and more excess fat, it causes a stress response in the adipose tissue," explains research group leader Dr. Thomas Wunderlich. This stress response alerts the body's immune system, which in turn triggers inflammation in adipose tissue.
Chronic obesity puts the body under constant stress and inflammatory signals spread throughout the body. This ultimately leads to a reprogramming of immune cells, changing their function from cancer-fighting to tumor-promoting.
These new molecular-biological findings were recently published in the scientific journal Nature Communications. First author Claudia Wunderlich, who performed the majority of the studies, said: "Just because you're overweight does not mean you will immediately develop cancer. But when abnormal cells are present in the body, obesity can favour tumor growth.”
Not only does this study provide evidence on how obesity and colorectal cancer are related, but also additional encouraging findings. "Using mouse models, we were able to identify specific targets for possible therapeutic approaches in humans," explains Claudia Wunderlich.
The researchers already have promising results for reducing the risk of disease in obese mice. To do this, they either eliminated specific immune cell populations, or they genetically altered the animals so that certain immune cells could not be reprogrammed in the presence of a high-fat diet. In both cases, the inflammatory response was attenuated, abnormal cells were targeted for removal and the overall development of colon cancer was reduced.
Dr. Thomas Wunderlich
Max Planck Institute for Metabolism Research, Cologne
+49 221 47260 678
Claudia M. Wunderlich, P. Justus Ackermann, Anna Lena Ostermann, Petra Adams-Quack, Merly C. Vogt, My-Ly Tran, Alexei Nikolajev, Ari Waisman, Christoph Garbers, Sebastian Theurich, Jan Mauer, Nadine Hövelmeyer, F. Thomas Wunderlich.
Obesity exacerbates colitis-associated cancer via IL-6-regulated macrophage polarisation and CCL-20/CCR-6-mediated lymphocyte recruitment.
Nature Communications, 2018.
Dr. Annegret Burkert | Max-Planck-Institut für Stoffwechselforschung
Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland
Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy